Drug intelligence / Profile preview

miR-126

Development stage
Preclinical
Lead developer
Uppsala University
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

miR-126 is a microRNA (miRNA) that is highly expressed in endothelial cells and plays a pivotal role in maintaining vascular homeostasis, angiogenesis, and wound healing. In the context of oncology, miR-126 frequently functions as a tumor suppressor, and its expression is often significantly downregulated in various malignancies, including melanoma, breast cancer, and lung cancer. Research indicates that miR-126 modulates the tumor microenvironment by targeting the expression of proteins such as Vascular Cell Adhesion Molecule 1 (VCAM-1), thereby influencing tumor cell adhesion, migration, and invasiveness. Therapeutic strategies involving miR-126 typically focus on the use of miRNA mimics to restore its levels in cancer cells or the vasculature to inhibit tumor progression and improve clinical outcomes.

Other names
miR-126-3pmiR126-3pmiR 126-3pmiR-126-5pmiR126-5pmiR 126-5p
02

Targets

PIK3R2 (PI3K regulatory subunit beta)IRS1 (Insulin receptor substrate 1)VCAM1 (Vascular cell adhesion molecule 1)

Beyond the preview

Go deeper on miR-126.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-126.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call